About
Targeting Drug Delivery to Ileum
Areas of Focus
Categories
Drug Delivery & Formulation
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
535
By Phase
PHASE2: 2PHASE1: 1PHASE1/PHASE2: 1
By Status
NOT_YET_RECRUITING: 1RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06993428Lead Sponsor
A Trial With EMP16 in Preparation for Late Phase Studies
PHASE2Not yet recruiting
39 participants
Started: May 20, 2025 · Completed: Jul 29, 2025
NCT06013163Lead Sponsor
A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers
PHASE1Recruiting
20 participants
Started: Sep 22, 2023 · Completed: Dec 31, 2024
NCT05934110Lead Sponsor
Study Exploring the Supportive Effect of Acarbose in Weight Management
PHASE2Active, not recruiting
320 participants
Started: Apr 18, 2023 · Completed: Mar 15, 2024
NCT04521751Lead Sponsor
A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)
PHASE1/PHASE2Completed
156 participants
Started: May 7, 2020 · Completed: Aug 30, 2021
Locations (1)
Headquarters
Solna, Sweden
Map
Loading map...